Will Novavax Stock Ever Reach Its All-Time High Again?
Novavax (NASDAQ: NVAX) investors are no strangers to tragedy. On Feb. 9 in 2021, shares of the coronavirus vaccine developer hit their all-time high of $331.68. Are longtime shareholders doomed to heavy losses forever, or will Novavax return to its glory days?